CD33 and acute myeloid leukemia: The flow cytometric analysis revealed expression of PVR and PVRL2 on AML cell lines, all being CD33 positive (n = 9), and the majority of CD33+ AML blasts from untreated AML patients (n = 17; Fig. 1); see representative FACS plots in Supplemental Fig. 1).